Lactococcus

Lactococcus lactis is a Gram-positive, facultatively anaerobic, lactic acid bacterium best known as the workhorse of the dairy fermentation industry. It holds GRAS (Generally Recognized As Safe) status and has emerged as a versatile platform for probiotic and therapeutic protein delivery applications.

Industrial and Food Applications

  • Primary starter culture for cheese production, fermented milk, buttermilk, and other dairy products.
  • Produces nisin, a lantibiotic (antimicrobial peptide) effective against Gram-positive pathogens including Listeria, Staphylococcus, and Clostridium species.
  • Nisin production has attracted interest as a natural food preservative and potential adjunct to antibiotic therapy.
  • Homofermentative metabolism converts lactose to lactic acid with high efficiency [1].

Metal Dependencies

  • Manganese: L. lactis relies on Mn-superoxide dismutase (MnSOD) for oxidative stress defense, unlike most bacteria that use Fe-SOD. This Mn-dependency reduces its vulnerability to iron-limitation strategies of nutritional immunity.
  • Zinc: Zn-dependent cell-envelope proteinases (PrtP) are essential for casein degradation during dairy fermentation. zinc availability thus directly influences the proteolytic capacity and growth rate of L. lactis.

Disease-Associated Microbiome Findings

Autoimmune Thyroid Disease

  • Berberine supplementation in Graves' disease patients increased L. lactis abundance alongside clinical improvement. L. lactis was negatively correlated with FT3, FT4, and TRAb but positively correlated with TSH, suggesting a role in thyroid homeostasis [2].

Colorectal Cancer

  • Relatively higher abundance of Lactococcus observed in CRC patients in some cohorts, though its role in CRC pathogenesis is unclear and may reflect dietary confounders [3].

Neurodegenerative Disease

  • Depleted in Parkinson's disease patients, consistent with loss of beneficial lactic acid bacteria in neurodegenerative conditions [4].

Multiple Sclerosis

  • Associated with diet and MS status in pediatric cohorts, particularly in the context of Mediterranean dietary patterns [5].

Autism Spectrum Disorder

  • Altered abundance in ASD children with GI symptoms, sharing evolutionary lineage with Streptococcus within the Lactobacillales order [6].

Biotherapeutic Delivery Platform

L. lactis is increasingly used as a live biotherapeutic delivery platform:

  • Engineered strains can secrete anti-inflammatory cytokines (IL-10), trefoil factors, and antigenic proteins directly in the gut lumen.
  • Its inability to colonize the gut permanently is actually advantageous for controlled, transient therapeutic delivery.
  • Investigational applications include mucosal vaccine delivery and local treatment of inflammatory bowel disease.

Key Sources

Connections

  • probiotics — GRAS probiotic with established safety profile
  • manganese — Mn-SOD dependency distinguishes it from Fe-dependent organisms
  • zinc — Zn-dependent proteolytic system essential for dairy fermentation
  • nutritional immunity — Mn-centered metabolism may evade Fe-restriction strategies
  • inflammatory bowel disease — engineered L. lactis as mucosal delivery platform
  • — foundational organism in dairy fermentation
  • bifidobacterium — co-occurring beneficial taxon in probiotic formulations

References (6)

  1. Kosuke Fujimoto, Daichi Miyaoka, Satoshi Uematsu (2022). Characterization of the human gut virome in metabolic and autoimmune diseases. Inflammation and Regeneration. doi:10.1186/s41232-022-00218-6
  2. Han Z, Cen C, Ou Q et al. (2022). Han et al. 2022 — The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome. Frontiers in Immunology. doi:10.3389/fimmu.2021.826067
  3. Zhiguang Gao, Bomin Guo, Renyuan Gao et al. (2015). Microbiota disbiosis is associated with colorectal cancer. Frontiers in Microbiology. doi:10.3389/fmicb.2015.00020
  4. Khatoon S, Kalam N, Rashid S et al. (2023). Effects of gut microbiota on neurodegenerative diseases. Frontiers in Aging Neuroscience. doi:10.2147/DDDT.S580330
  5. Mirza AI, Zhu F, Knox N et al. (2024). Mediterranean Diet and Associations with the Gut Microbiota and Pediatric-Onset Multiple Sclerosis Using Trivariate Analysis. Communications Medicine. doi:10.1038/s43856-024-00565-0
  6. Hui Wang, Shu Liu, Liqing Xie et al. (2023). Wang 2023 — Gut Microbiota Signature in Children with ASD Who Suffered from Chronic Gastrointestinal Symptoms. BMC Pediatrics. doi:10.1186/s12887-023-04292-8